Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
US FDA approves FARXIGA™ (dapagliflozin) tablets for the treatment of adult patients with type 2 diabetes
-
MedImmune and Immunocore enter immunotherapy agreement to develop novel cancer therapies
-
AstraZeneca and Bristol-Myers Squibb announce US FDA approval of FARXIGA™ (dapagliflozin)
-
AstraZeneca and Shionogi settle arbitration and extend licence agreement for CRESTOR®
-
AstraZeneca to acquire Bristol-Myers Squibb share of global diabetes alliance assets
-
AstraZeneca statement in response to reports of a launch of esomeprazole strontium product in the US
-
AstraZeneca announces top-line results from phase III monotherapy study of lesinurad in gout patients
-
FDA Advisory Committee votes on investigational medicine metreleptin
-
FDA Advisory Committee recommends the investigational SGLT2 inhibitor dapagliflozin for treatment of type 2 diabetes in adults
-
AstraZeneca donates Brixham Environmental Laboratory to Plymouth University
Latest articles and press releases
All of our latest press releases and articles are available to explore
